BiomX  logo
BiomX PHGE
€ 2.48 -2.68%

Geschäftsbericht 2025
hinzugefügt 19.02.2026

report update icon

BiomX Langfristiger Schuldenstrom 2011-2026 | PHGE

Langfristiger Schuldenstrom Jährlich BiomX

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.44 M 1.13 M 666 K 687 K - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
1.44 M 666 K 980 K

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
9.96 M $ 22.56 2.13 % $ 3.74 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
argenx SE argenx SE
ARGX
10.8 M $ 785.07 2.57 % $ 25 B niderlandNiderland
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Akebia Therapeutics Akebia Therapeutics
AKBA
3.55 M $ 1.43 3.62 % $ 368 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
45.5 M $ 327.25 2.42 % $ 42.9 B usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.9 3.7 % $ 9.38 B australiaAustralia
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.49 9.56 % $ 397 M britainBritain
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 20.4 -0.87 % $ 954 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.18 1.21 % $ 447 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.66 3.5 % $ 16.7 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
208 K - -2.5 % $ 5.88 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 24.61 5.76 % $ 3.13 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Cabaletta Bio Cabaletta Bio
CABA
3.46 M $ 3.09 0.65 % $ 310 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
7 K - - $ 3.45 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Codiak BioSciences Codiak BioSciences
CDAK
2.66 M - -55.98 % $ 2.15 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
1.35 M - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
1.38 M - - $ 1.41 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Celldex Therapeutics Celldex Therapeutics
CLDX
1.55 M $ 32.41 3.38 % $ 2.15 B usaUSA
Celsion Corporation Celsion Corporation
CLSN
406 K - -6.63 % $ 13.9 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Chimerix Chimerix
CMRX
642 K - - $ 756 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
1.16 M - - $ 401 M usaUSA